
‘Riding the hype': Fans paying a premium to see first-place Toronto Blue Jays
The Blue Jays owned a record under .500 back in the spring, and looked poised for another middling campaign with little playoff hope.
Things then drastically turned around on the field. Toronto now sits first in the American League East.
And tickets are a hot commodity — often at a hefty price.
Getting into Rogers Centre to see Canada's only Major League Baseball team has quickly morphed into a costly endeavour this summer that has surprised some fans.
A recent sold-out series against the New York Yankees saw the cheapest seats on resale sites going for more than $200 apiece, while a ticket in the 500 level for Friday's series-opener with the Kansas City Royals was in the neighbourhood of $80 as of Wednesday afternoon — more than double face value.
Gardiner and her family have two season tickets near the visitors dugout. The tech consultant, who's had seats since Toronto's 2015 playoff run, sold most of her extras at cost to friends last season.
After the Jays' underwhelming start to 2025, interest dropped to near zero.
'We were posting on social media three days before a game saying, 'We can't make it and if you want the tickets let me know and they're yours,'' Gardiner said. 'They were free and people weren't taking them.'
Toronto's surge up the standings signalled a drastic shift across the ticket market.
Fans can make purchases directly from the team through Ticketmaster, while the website also has verified resale options — usually at an inflated price — similar to other big-hitters like SeatGeek and StubHub when supply is scarce.
Jagger Long, who runs Toronto-based resale website Karma Tickets, said a number of factors, including summer holidays, tourism and a winning team are contributing to the spikes.
'We're riding the hype of the Jays,' he said. 'People are spending the money. If they weren't, the prices would come down.'
A multi-million dollar renovation of Rogers Centre that improved sightlines, added more bars, communal areas and other amenities has also raised the stakes, Long said.
'They've done a great job of turning it into more of a social event,' he said.
That mainly happens in the common areas where general admission tickets — standing room, without a seat — can be purchased for a face value of roughly $20.
But those tickets — along with blocks of seats in the 500s — are often snapped up by scalpers or fellow fans looking to make a quick buck, Long said. General admission seats for Toronto's opener against Kansas City were priced around $50 and up for resale Wednesday.
'People are watching the market,' said Long, who added website algorithms can boost prices automatically when tickets are at a premium. 'Even average fans, professional ticket sellers, part-time ticket sellers, they watch. They treat it like a part-time job or a full-time job.'
The Jays said in a statement the club encourages fans to plan ahead and purchase tickets well in advance of games. The team noted there are plenty of seats available for series later in August and September.
Long agreed getting tickets early is the best practice, but added scanning resale options for popular games can still garner good results.
'Jot down the price and then go back in a few days,' he said. 'If the prices haven't really moved, that's an indicator … you eventually might find a hidden gem.'
The face value of Gardiner's tickets sit at just over $100 each per game. She hasn't looked to make a profit in the past, but sold for as much as $350 apiece for the Yankees series, and got $450 this weekend.
Thursdays
Keep up to date on sports with Mike McIntyre's weekly newsletter.
Prices for season-ticket holders jumped significantly following the Rogers Centre renovations. Gardiner said she knows a number of fellow fans — including some with tickets since Day 1 back in 1977 at Exhibition Stadium — who have gone that route to maintain their small pieces of baseball real estate.
The financial calculus of attending Jays games aside, Gardiner said the energy at the ballpark is comparable to when she first bought in a decade ago.
'It's like being there in 2015,' she said. 'There was something different, and that's what it's feeling like in that building.
'Everyone keeps saying it's like a playoff game. It is electric.'
This report by The Canadian Press was first published July 30, 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
28 minutes ago
- Cision Canada
Oppenheimer Holdings Inc. Reports Second Quarter 2025 Earnings
NEW YORK, Aug. 1, 2025 /CNW/ - Oppenheimer Holdings Inc. (NYSE: OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the second quarter of 2025, compared with net income of $10.3 million or $0.99 basic earnings per share for the second quarter of 2024. Revenue for the second quarter of 2025 was $373.2 million, an increase of 12.9%, compared to revenue of $330.6 million for the second quarter of 2024. , President and CEO commented, "The Firm's improved operating results for the quarter showcase the strength of our businesses and the maturing of investments in experienced team members over the past several years. At the outset of the quarter, recession fears mounted as announced policies on trade drove significant market volatility and triggered a large selloff in the equity markets. As tariffs were suspended, the markets broadly rallied with both the NASDAQ and S&P 500 reaching new record highs to close out the quarter. Concerns remained over tariff-induced inflation, a potentially softening labor market and conflict in the Middle East. Rising markets proved quite favorable to our Wealth Management business revenue, with the rally driving assets under management ("AUM") to a fresh record, resulting in higher asset-based advisory fees when compared with the prior year period. Retail trading volumes, driven by investor interest, also remained robust, boosting commission revenue. However, the fees we earn on our FDIC sweep program are reduced from the prior year period due to lower deposit balances as clients sought higher returns in money market funds and other investments. The Capital Markets businesses showed a substantial increase in total revenue. Institutional trading volumes were strong during the quarter due in part to increased volatility, which buoyed our sales and trading revenue. Investment Banking revenue also improved on the back of more advisory assignments that closed in the quarter and robust underwriting levels as capital markets re-opened. We are hopeful that higher deal volumes will continue in the latter half of the year as policymakers firm up key trade policy decisions and concerns around recession recede. The Firm continues to maintain an unlevered balance sheet and ended the quarter with its capital reaching yet another all-time high. As we move into the second half of the year, we remain optimistic about our capabilities and our ability to continue delivering high quality services to our clients." (1) Attributable to Oppenheimer Holdings Inc. (2) Represents book value less goodwill and intangible assets divided by number of shares outstanding. Highlights Increased revenue for the second quarter of 2025 was primarily driven by significantly higher investment banking revenue due to an uptick in underwriting volumes and larger advisory mandates, an increase in transaction-based commissions and greater advisory fees attributable to a rise in billable AUM Rising markets lifted assets under administration and under management to fresh records at June 30, 2025 Compensation expenses increased from the prior year quarter largely as the result of higher production and salary-related expenses Non-compensation expenses increased from the prior year quarter primarily due to higher technology related expenses and greater travel and other miscellaneous costs Total stockholders' equity, book value and tangible book value per share reached new record highs as a result of positive earnings Wealth Management Wealth Management reported revenue for the current quarter of $246.4 million, 5.1% higher compared with the prior year period. Pre-tax income was $62.8 million in the current quarter, a decrease of 2.2% compared with a year ago. Financial advisor headcount at the end of the current quarter was 927, compared to 934 at the end of the second quarter of 2024. Revenue: Retail commissions increased 3.6% from the prior year period primarily due to higher retail trading activity Advisory fees increased 7.2% due to higher AUM during the billing period Bank deposit sweep income decreased $6.2 million from a year ago due to lower cash sweep balances and lower short-term interest rates Interest revenue was flat compared to the prior year period Other revenue increased from a year ago primarily due to an increase in the cash surrender value of Company-owned life insurance policies, which fluctuates based on changes in the fair value of the policies' underlying investments Assets under Management (AUM): AUM reached a record high of $52.8 billion at June 30, 2025, which is the basis for advisory fee billings for July 2025 The increase in AUM from the prior year period was comprised of higher asset values of $8.9 billion on existing client holdings, offset by net distributions of $3.6 billion Total Expenses: Compensation expenses increased 7.1% from the prior year period primarily due to higher production related expenses and higher deferred compensation costs, partially offset by lower expenses associated with share appreciation rights Non-compensation expenses increased 9.7% from a year ago primarily due to an increase in interest and other miscellaneous expenses Capital Markets Capital Markets reported revenue for the current quarter of $123.0 million, 33.5% higher when compared with the prior year period. Pre-tax loss was $3.9 million compared with a pre-tax loss of $21.8 million a year ago. Revenue: Investment Banking Advisory fees earned from investment banking activities increased 83.0% compared with the prior year period due to increased deal volumes and larger mandate sizes Equities underwriting fees increased 9.1% compared with the prior year period primarily due to higher underwriting fees associated with larger deal sizes Fixed income underwriting fees increased 115.3% compared with the prior year period primarily due to higher corporate and sovereign issuance activity levels Sales and Trading Equities sales and trading revenue increased 20.2% compared with the prior year period mostly due to higher trading volumes and greater options-related commissions revenue Fixed income sales and trading revenue increased 23.6% compared with a year ago largely due to higher trading volumes and interest income on trading inventory Total Expenses: Compensation expenses increased 10.0% compared with the prior year period largely due to greater production-related expenses Non-compensation expenses were 13.8% higher than a year ago primarily due to an increase in communication and technology expenses and travel-related costs Other Matters The Board of Directors announced a quarterly dividend of $0.18 per share payable on August 29, 2025 to holders of Class A non-voting and Class B voting common stock of record on August 15, 2025 Compensation expense as a percentage of revenue was modestly lower at 64.1% during the current period versus 66.8% during the same period last year The effective tax rate for the current period was 32.7% compared with 35.3% for the prior year period, as the impact of certain unfavorable permanent items and nondeductible foreign losses was reduced in the current period Company Information Oppenheimer Holdings Inc., through its operating subsidiaries, is a leading middle market investment bank and full service broker-dealer that is engaged in a broad range of activities in the financial services industry, including retail securities brokerage, institutional sales and trading, investment banking (corporate and public finance), equity and fixed income research, market-making, trust services, and investment advisory and asset management services. With roots tracing back to 1881, the Company is headquartered in New York and has 89 retail branch offices in the United States and institutional businesses located in London, Tel Aviv, and Hong Kong. Forward-Looking Statements This press release includes certain "forward-looking statements" relating to anticipated future performance. For a discussion of the factors that could cause future performance to be different than anticipated, reference is made to Factors Affecting "Forward-Looking Statements" and Part 1A – Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Oppenheimer Holdings Inc. Consolidated Income Statements (Unaudited) ('000s, except number of shares and per share amounts) For the Three Months Ended June 30, For the Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change REVENUE Commissions $ 110,025 $ 97,055 13.4 $ 220,903 $ 192,905 14.5 Advisory fees 125,628 117,197 7.2 254,431 232,044 9.6 Investment banking 43,533 29,119 49.5 91,156 79,656 14.4 Bank deposit sweep income 28,654 34,846 (17.8) 58,729 71,531 (17.9) Interest 38,017 34,805 9.2 74,386 61,571 20.8 Principal transactions, net 14,532 10,074 44.3 23,507 28,308 (17.0) Other 12,789 7,493 70.7 17,891 17,712 1.0 Total revenue 373,178 330,589 12.9 741,003 683,727 8.4 EXPENSES Compensation and related expenses 239,074 220,727 8.3 466,165 442,440 5.4 Communications and technology 26,204 24,682 6.2 52,386 49,258 6.4 Occupancy and equipment costs 15,578 15,516 0.4 31,587 31,364 0.7 Clearing and exchange fees 7,041 6,780 3.8 14,793 12,622 17.2 Interest 22,529 21,980 2.5 43,925 42,528 3.3 Other 30,542 25,039 22.0 58,561 52,195 12.2 Total expenses 340,968 314,724 8.3 667,417 630,407 5.9 Pre-Tax Income 32,210 15,865 103.0 73,586 53,320 38.0 Income tax provision 10,536 5,599 88.2 21,257 17,310 22.8 Net Income $ 21,674 $ 10,266 111.1 $ 52,329 $ 36,010 45.3 Less: Net loss attributable to non-controlling interest, net of tax — — — (310) Net income attributable to Oppenheimer Holdings Inc. $ 21,674 $ 10,266 111.1 $ 52,329 $ 36,320 44.1 Earnings per share attributable to Oppenheimer Holdings Inc. Basic $ 2.06 $ 0.99 108.1 $ 4.99 $ 3.49 43.0 Diluted $ 1.91 $ 0.92 107.6 $ 4.63 $ 3.29 40.7 Weighted average number of common shares outstanding Basic 10,520,219 10,327,818 1.9 10,493,145 10,367,636 1.2 Diluted 11,349,049 11,111,903 2.1 11,308,979 11,083,422 2.0 Period end number of common shares outstanding 10,517,924 10,327,510 1.8 10,517,924 10,327,510 1.8 SOURCE Oppenheimer Holdings Inc.

National Post
28 minutes ago
- National Post
Belgravia Hartford Doubles Bitcoin Treasury to 83 Bitcoin with Acquisition of an Additional 42 Bitcoin
Article content TORONTO — Belgravia Hartford Capital Inc. (CSE: BLGV) (OTC: BLGVF) (FRA: ECA) ('Belgravia' or the 'Company') is pleased to announce the acquisition of an additional 42.3776327 Bitcoin (BTC) on July 31, 2025, marking Belgravia's largest single-day Bitcoin purchase to date. This acquisition surpasses Belgravia's prior milestone of 25 BTC acquired on July 24, 2025. Article content As a result of this latest transaction, Belgravia has effectively doubled its Bitcoin holdings, bringing its total treasury to 83.14954408 BTC. Article content Article content 'We have demonstrated our commitment to acquiring Bitcoin with speed and conviction,' said Mehdi Azodi, President and CEO of Belgravia Hartford. 'Belgravia has acted decisively at every opportunity, and we intend to build on this momentum as we continue to expediate our Bitcoin treasury strategy.' Article content The transaction was executed through Coinsquare's regulated over-the-counter (OTC) trading desk at 11:25 a.m. EST, at an average price of USD $117,986.77 per BTC. Article content Article content

National Post
2 hours ago
- National Post
Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025
Article content TORONTO — Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the 'Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open. Article content The Company will host a conference call to discuss its results with details as follows: Article content Article content Date: Wednesday, August 13, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use this link: To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call. Article content To access the webcast: Participants will receive their details via email. Article content A replay of the webcast will be available within 24 hours after the conclusion of the call at and will be archived for a period of 90 days following the call. Article content About Organigram Article content Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. Article content Organigram Global is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram Global has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, DEBUNK and Collective Project. Organigram Global operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Article content Forward-Looking Information Article content This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information including expectations regarding market performance, involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram Global to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis, and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. Article content Article content Article content Article content Article content Article content